Toril Holien
Norges teknisk-naturvitenskaplige universitet
H-index: 28
Europe-Norway
Top articles of Toril Holien
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Genome-Wide CRISPR/Cas9 Knock-out Screen Identifies Apoptosis-Relevant Genes in Multiple Myeloma | Blood | Clara Leticia Andersson-Rusch Ingrid Quist-Løkken Pål Sætrom Vidar Beisvåg Milosz Rolinski | 2023/11/28 |
P-364 Novel FKBP12 targeting PROTACs enhances BMP-induced apoptosis in multiple myeloma | Clinical Lymphoma Myeloma and Leukemia | Ingrid Quist-Lokken Michael Walz Felix Hausch Toril Holien | 2023/9/1 |
Targeting FKBP12 enables bone morphogenetic proteins to kill multiple myeloma cells via ALK2 | Ingrid Quist-Løkken Clara Andersson-Rusch Martin Haugrud Kastnes Jürgen Markus Kolos Jerome Jatzlau | 2023/8/18 | |
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells | Scientific Reports | Clara Andersson-Rusch Bin Liu Ingrid Quist-Løkken Paul D Upton Oddrun Elise Olsen | 2023/4/24 |
FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells | Cell Communication and Signaling | Ingrid Quist-Løkken Clara Andersson-Rusch Martin Haugrud Kastnes Jürgen Markus Kolos Jerome Jatzlau | 2023/1/30 |
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines | Frontiers in Oncology | Mariaserena Giliberto Leonardo Miranda Santana Toril Holien Kristine Misund Sigve Nakken | 2022/11/29 |
Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies | Molecular Oncology | Katrine Melvold Mariaserena Giliberto Linda Karlsen Pilar Ayuda‐Durán Robert Hanes | 2022/3 |
Article II. Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B cell malignancies | Application of drug sensitivity screening in B-cell malignancies for informing precision medicine strategies | Katrine Melvold Mariaserena Giliberto Linda Karlsen Pilar Ayuda-Durán Richard Rosenquist | 2022 |
Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3. 1] aza-amides | Chemical science | Jürgen M Kolos Sebastian Pomplun Sascha Jung Benedikt Rieß Patrick L Purder | 2021 |
Application of photodynamic therapy with 5-aminolevulinic acid to extracorporeal photopheresis in the treatment of patients with chronic graft-versus-Host disease: A first-in … | Pharmaceutics | Eidi Christensen Olav A Foss Petter Quist-Paulsen Ingrid Staur Frode Pettersen | 2021/9/26 |
Receptor binding competition: A paradigm for regulating TGF-β family action | Erik Martinez-Hackert Anders Sundan Toril Holien | 2021/2/1 | |
Bone morphogenetic protein 4 gene therapy in mice inhibits myeloma tumor growth, but has a negative impact on bone | Journal of Bone and Mineral Research Plus | Marita Westhrin Toril Holien Muhammad Zahoor Siv Helen Moen Glenn Buene | 2020/1/1 |
Modification of extracorporeal photopherisis technology with porphyrin precursors | 2020/6/30 | ||
Chemical, physical and biological triggers of evolutionary conserved Bcl-xL-mediated apoptosis | Cancers | Aleksandr Ianevski Evgeny Kulesskiy Klara Krpina Guofeng Lou Yahyah Aman | 2020/6/25 |
Activins as dual specificity TGF-β family molecules: SMAD-activation via activin-and BMP-type 1 receptors | Biomolecules | Oddrun Elise Olsen Hanne Hella Samah Elsaadi Carsten Jacobi Erik Martinez-Hackert | 2020/3/29 |
Selective killing of activated t cells by 5-aminolevulinic acid mediated photodynamic effect: Potential improvement of extracorporeal photopheresis | Cancers | Sagar Darvekar Petras Juzenas Morten Oksvold Andrius Kleinauskas Toril Holien | 2020/2/6 |
Co-Authors
